Evidence map›Paper›PMID 39191738›Full record

ArticleCell death & disease2024

Correction: H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance.

Fei Peng, Ting-Ting Li, Kai-Li Wang, Guo-Qing Xiao, Ju-Hong Wang, Hai-Dong Zhao, Zhi-Jie Kang, Wen-Jun Fan, Li-Li Zhu, Mei Li and 7 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Fei Peng *Institute of Cancer Stem Cell, Dalian Medical University, Dalian; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.
Ting-Ting Li *Institute of Cancer Stem Cell, Dalian Medical University, Dalian; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.
Kai-Li Wang *Institute of Cancer Stem Cell, Dalian Medical University, Dalian; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.
Guo-Qing XiaoDepartment of Breast Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
Ju-Hong WangDepartment of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China.
Hai-Dong ZhaoDepartment of Breast Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, 116023, China.
Zhi-Jie KangInstitute of Cancer Stem Cell, Dalian Medical University, Dalian; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.
Wen-Jun FanInstitute of Cancer Stem Cell, Dalian Medical University, Dalian; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.
Li-Li ZhuDepartment of Obstetrics and Gynaecology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China.
Mei LiDepartment of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China.
Bai CuiInstitute of Cancer Stem Cell, Dalian Medical University, Dalian; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.
Fei-Meng ZhengInstitute of Cancer Stem Cell, Dalian Medical University, Dalian; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.
Hong-Jiang WangDepartment of Breast Surgery, The First Affiliated Hospital, Dalian Medical University, Dalian, 116011, China.
Eric W-F LamDepartment of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
Bo WangDepartment of Medical Oncology, The Eastern Hospital of The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510700, China. wangb68377@sina.com.
Jie XuInstitute of Cancer Stem Cell, Dalian Medical University, Dalian; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China. xujie@dmu.edu.cn.
Quentin LiuInstitute of Cancer Stem Cell, Dalian Medical University, Dalian; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China. liuq9@mail.sysu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39191738
PMCPMC11349888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.